Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Junichi Oshida is active.

Publication


Featured researches published by Junichi Oshida.


Archives of Biochemistry and Biophysics | 1985

The stereochemical configuration of the natural 1α,25-dihydroxyvitamin D3-26,23-lactone

Seiichi Ishizuka; Junichi Oshida; Hideki Tsuruta; Anthony W. Norman

Abstract Four possible diastereoisomers of 1α,25-dihydroxyvitamin D3-26,23-lactone were chemically synthesized and compared with the natural metabolite by high-pressure liquid chromatography. The four synthetic diastereoisomers of 1α,25-dihydroxyvitamin D3-26,23-lactone could be separated into three peaks by high-pressure liquid chromatography. The naturally occurring 1α,25-dihydroxyvitamin D3-26,23-lactone isolated from dog serum and in vitro incubation of chick kidney homogenates comigrated with 23(S)25(R)-1α,25-dihydroxyvitamin D3-26,23-lactone. The four diastereoisomers of 1α,25-dihydroxyvitamin D3-26,23-lactone were tested against naturally occurring 1α,25-dihydroxyvitamin D3-26,23-lactone to determine their relative competition in the 1α,25-dihydroxyvitamin D3-specific cytosol receptor binding assay for 1α,25-dihydroxyvitamin D3. 23(S)25(S)-1α,25-Dihydroxyvitamin D3-26,23-lactone was the best competitor followed by 23(R)25(R)-1α,25-dihydroxyvitamin D3-26,23-lactone and 23(R)25(S)-1α,25-dihydroxyvitamin D3-26,23-lactone, and 23(S)25(R)-1α,25-dihydroxyvitamin D3-26,23-lactone was the poorest competitor. Natural 1α,25-dihydroxyvitamin D3-26,23-lactone isolated from dog serum had almost the same binding affinity as that of 23(S)25(R)-1α,25-dihydroxyvitamin D3-26,23-lactone. These data unequivocally demonstrate that the stereochemistry of the natural 1α,25-dihydroxyvitamin D3-26,23-lactone has the 23(S) and 25(R) configuration.


Archive | 1982

Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom

Junichi Oshida; Osamu Nishikawa; Hideki Tsuruta; Toru Takeshita; Itaru Yamamoto; Kenji Ishimaru


Archive | 1988

4H-3,1-benzoxazin-4-one compounds and pharmaceutical compositions thereof for the inhibition of serine proteases

Masayuki Kokubo; Katsuhiko Fujii; Junichi Oshida; Koji Tomimori; Yasuhide Uejima


Archive | 1988

4h-3,1-benzoxazin-4-one compounds and serine protease-inhibiting medicinal composition containing same

Masayuki Kokubo; Katsuhiko Fujii; Junichi Oshida; Koji Tomimori; Yasuhide Uejima


Archive | 1991

4h-3,1-benzoxazin-4-one compound and elastase inhibitor composition containing the same

Junichi Oshida; Hiroshi Kawabata; Yoshinori Kato; Masayuki Kokubo; Yasuhide Uejima; Osami Sato; Katsuhiko Fujii


Chemical & Pharmaceutical Bulletin | 1984

An Improved Synthesis of 1α-Hydroxy-7-dehydrocholesterol Derivatives

Osamu Nishikawa; Junichi Oshida; Hideki Tsuruta


Archive | 1983

25-hydroxyvitamin d3-26,23-lactone derivative and its preparation

Kenji Ishimaru; Junichi Oshida; Hideki Tsuruta


Archive | 1981

Novel vitamin d3 derivative and its preparation

Kenji Ishimaru; Junichi Oshida; Hideki Tsuruta


Archive | 1991

4h-3,1-benzoxazin-4-one compounds and their pharmaceutical compositions for inhibiting elastase

Junichi Oshida; Hiroshi Kawabata; Yoshinori Kato; Masayuki Kokubo; Yasuhide Uejima; Osami Sato; Katsuhiko Fujii


Archive | 1988

4h-3,1-benzoxazin-4-on-verbindungen und serin protease-inhibierende arzneimittel. 4H-3,1-benzoxazin-4-one compounds and serine protease inhibiting drug.

Masayuki Kokubo; Katsuhiko Fujii; Junichi Oshida; Koji Tomimori; Yasuhide Uejima

Collaboration


Dive into the Junichi Oshida's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Toru Takeshita

Tokyo Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge